Literature DB >> 3950397

Detection of Clostridium difficile toxins by enzyme immunoassay.

C Krishnan.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) for the rapid diagnosis of antibiotic-associated colitis (AAC) is presented. Commercially available antisera to Clostridium difficile toxins contain antibodies to other antigens found in non-toxigenic C. difficile and other bacteria. Removal of these unwanted antibodies by absorption increased the specificity of ELISA for detection of C. difficile toxins. Specimens tested included 40 faecal extracts positive for cytotoxicity from cases of AAC, 30 diarrhoeic and 30 well-formed stools negative for cytotoxicity and 50 culture filtrates of toxigenic and non-toxigenic C. difficile and other clostridial species. Use of absorbed sera reduced false-positive reactions observed with faecal specimens from 23 to 8%. About 90% of specimens that were positive by the tissue culture cytotoxicity test were positive by ELISA using the absorbed sera. The relative merits of ELISA and other methods for the rapid diagnosis of AAC are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950397      PMCID: PMC2129589          DOI: 10.1017/s0022172400062471

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  16 in total

1.  Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens.

Authors:  B E Laughon; R P Viscidi; S L Gdovin; R H Yolken; J G Bartlett
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

2.  Comparison of bacterial isolation, cytotoxicity assay, and counterimmunoelectrophoresis for the detection of Clostridium difficile and its toxin.

Authors:  W Jarvis; O Nunez-Montiel; F Thompson; V Dowell; M Towns; G Morris; E Hill
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

Review 3.  Antimicrobial agent-associated colitis and diarrhea: historical background and clinical aspects.

Authors:  W L George
Journal:  Rev Infect Dis       Date:  1984 Mar-Apr

4.  Criteria for detection of Clostridium difficile toxin production by counterimmunoelectrophoresis.

Authors:  R P Rennie; J M Elliott; M A Nardini; J H Thornley
Journal:  J Clin Microbiol       Date:  1984-11       Impact factor: 5.948

5.  Improved immunologic detection of Clostridium difficile antigen by counterimmunoelectrophoresis.

Authors:  R W Ryan; I Kwasnik; R C Tilton
Journal:  Diagn Microbiol Infect Dis       Date:  1983-03       Impact factor: 2.803

6.  Problems associated with counterimmunoelectrophoresis assays for detecting Clostridium difficile toxin.

Authors:  S E West; T D Wilkins
Journal:  J Clin Microbiol       Date:  1982-02       Impact factor: 5.948

7.  Evaluation of the usefulness of counterimmunoelectrophoresis for diagnosis of Clostridium difficile-associated colitis in clinical specimens.

Authors:  T C Wu; J C Fung
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

8.  Improved enzyme immunoassays for the detection of antigens in fecal specimens. Investigation and correction of interfering factors.

Authors:  R Viscidi; B E Laughon; M Hanvanich; J G Bartlett; R H Yolken
Journal:  J Immunol Methods       Date:  1984-02-24       Impact factor: 2.303

9.  Enzyme-linked immunosorbent assay for Clostridium difficile toxin A.

Authors:  D M Lyerly; N M Sullivan; T D Wilkins
Journal:  J Clin Microbiol       Date:  1983-01       Impact factor: 5.948

10.  Latex agglutination test for detection of Clostridium difficile toxin in stool samples.

Authors:  M S Shahrabadi; L E Bryan; D Gaffney; S E Coderre; R Gordon; C H Pai
Journal:  J Clin Microbiol       Date:  1984-09       Impact factor: 5.948

View more
  7 in total

1.  Monoclonal antibodies specific for Clostridium difficile toxin B and their use in immunoassays.

Authors:  F Müller; C Stiegler; U Hadding
Journal:  J Clin Microbiol       Date:  1992-06       Impact factor: 5.948

2.  Evaluation of a commercial enzyme immunoassay kit for the detection of Clostridium difficile toxin A.

Authors:  S P Borriello; T Vale; J S Brazier; S Hyde; E Chippeck
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

Review 3.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

Review 4.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

5.  Development of a rapid enzyme immunoassay for Clostridium difficile toxin A and its use in the diagnosis of C. difficile-associated disease.

Authors:  J R DiPersio; F J Varga; D L Conwell; J A Kraft; K J Kozak; D H Willis
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

6.  Development of an ELISA kit using monoclonal antibody to Clostridium difficile toxin A.

Authors:  Si-Wu Fu; Ya-Li Zhang; Dian-Yuan Zhou
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

7.  Clostridium difficile Infections: What Every Clinician Should Know.

Authors:  James Yoo; Amy Lee Lightner
Journal:  Perm J       Date:  2010
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.